Training in HIV Persistence, Co-morbidities and Therapeutics
HIV 持续性、合并症和治疗方面的培训
基本信息
- 批准号:10326881
- 负责人:
- 金额:$ 9.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
HIV/AIDS once constituted a lethal diagnosis that ravaged many communities and has now become for
some a chronic disease with associated co-morbidities. Likewise, our historic research successes in deciphering
the mechanisms of fundamental HIV pathogenesis must now be directed to new questions about HIV elimination,
vaccines and therapeutic development, and efforts to treat and prevent subsequent disorders among people
surviving the disease. Researchers focused on these questions, with specific skillsets and knowledge, attractive
to multiple career paths, are needed to address these emerging challenges in HIV/AIDS disease. The overall
goal of this T32 is to prepare doctoral students with the knowledge, methodologic, analytic and leadership skills
to become successful future HIV research investigators. To achieve these goals, we will (A) Provide intensive
didactic education in HIV/AIDS research. A new required course in HIV Persistence will be offered to complement
a core didactic research curriculum. Research in progress will be shared among trainees and experts at an
annual retreat, and a catalog of elective courses will round out opportunities to build HIV knowledge in three
major emphasis areas: (i) cure research, including T-cell therapy and the reversal of viral latency; (ii) co-
morbidities, including malignancies and CNS disease; and (iii) prevention research, including vaccines and novel
therapeutics; (B) Recruit two outstanding doctoral students per year for 2 years of support with activities to
accelerate their progression to independence. Each trainee will have an individualized project characterized by
a) multiple-mentor teams to aid in the design and implementation of hypothesis-driven research projects, b) a
curriculum to build HIV specific knowledge and research skill sets, c) professional development including
presentation skills and grant-writing d) strong exposure including participation in group-based externship
opportunities in multiple career paths for HIV scientists, and strong programmatic oversight; and (C) Cultivate a
local infrastructure and multi-departmental culture of collaboration to support HIV research training. This
application joins faculty from multiple GW departments and schools, as well as the District of Columbia Center
for AIDS Research (DC CFAR) to introduce new perspectives and fresh ideas that will collectively offer
outstanding collaborative training in cross-cutting high priority areas of HIV research. Enhanced cross-school
and regional investigator orientation and networks, and research progress reports and meetings are intrinsic to
this plan. New approaches to enhance mentor development will be expanded and institutionalized to strengthen
faculty mentoring practices in effective autonomy-supportive mentoring.
艾滋病毒/艾滋病曾经构成一种致命的诊断,它肆虐许多社区,现在已经成为
有些人是慢性疾病,并有相关的共病。同样,我们的历史研究在破译方面也取得了成功
HIV的基本致病机制现在必须指向关于消除HIV的新问题,
疫苗和治疗发展,以及治疗和预防人们随后的疾病的努力
在疾病中存活下来。研究人员专注于这些问题,具有特定的技能和知识,具有吸引力
要应对艾滋病毒/艾滋病方面的这些新挑战,就需要将职业道路扩展到多种职业道路。整体而言
这个T32的目标是培养博士生的知识,方法,分析和领导技能
成为未来成功的艾滋病毒研究调查人员。为了实现这些目标,我们将(A)提供密集的
艾滋病毒/艾滋病研究中的说教教育。将开设一门关于艾滋病毒持久性的新必修课,以补充
核心的教学研究课程。正在进行的研究将在学员和专家会议上分享
一年一度的静修和选修课程目录将在三年内提供建立艾滋病毒知识的机会
主要重点领域:(1)治愈研究,包括T细胞疗法和逆转病毒潜伏期;(2)共同
疾病,包括恶性肿瘤和中枢神经系统疾病;和(3)预防研究,包括疫苗和新技术
治疗学;(B)每年招收两名优秀博士生,为期两年,开展下列活动
加快他们走向独立的进程。每个学员都将有一个个性化的项目,其特点是
A)多名导师小组协助设计和实施假设驱动的研究项目,b)a
建立艾滋病毒专门知识和研究技能的课程,c)专业发展,包括
演示技巧和赠款撰写d)有很强的曝光率,包括参与基于团体的外部资助
艾滋病毒科学家在多种职业道路上的机会,以及强有力的方案监督;和(C)培养
地方基础设施和多部门协作文化,以支持艾滋病毒研究培训。这
应用程序加入了来自多个GW部门和学校以及哥伦比亚特区中心的教师
为艾滋病研究(DC CFAR)引入新的视角和新的想法,将共同提供
在艾滋病毒研究的交叉高度优先领域开展出色的协作培训。增强的跨校学习
以及区域调查员培训和网络,以及研究进展报告和会议是
这个计划。将扩大和制度化加强导师发展的新方法,以加强
教师辅导实践中有效的自主支持辅导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alberto Bosque其他文献
Alberto Bosque的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alberto Bosque', 18)}}的其他基金
Defining HIV Env protein expression in latently infected cells
定义潜伏感染细胞中的 HIV 包膜蛋白表达
- 批准号:
10762524 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening
用于广泛中和抗体筛选的超灵敏包膜检测分析
- 批准号:
10676393 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Pathways modulating memory-like properties in NK cells and their impact on HIV control
调节 NK 细胞记忆样特性的途径及其对 HIV 控制的影响
- 批准号:
10534402 - 财政年份:2022
- 资助金额:
$ 9.86万 - 项目类别:
Pathways modulating memory-like properties in NK cells and their impact on HIV control
调节 NK 细胞记忆样特性的途径及其对 HIV 控制的影响
- 批准号:
10673150 - 财政年份:2022
- 资助金额:
$ 9.86万 - 项目类别:
Training in HIV Persistence, Co-morbidities and Therapeutics
HIV 持续性、合并症和治疗方面的培训
- 批准号:
10657673 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Developing Pathogen Recognition Receptor Agonists as Latency Reversing Agents
开发病原体识别受体激动剂作为潜伏期逆转剂
- 批准号:
9501675 - 财政年份:2016
- 资助金额:
$ 9.86万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Research Grant
CAREER: Training Diverse Scientists to Design Bionanomaterials for Imaging and Labeling of Therapeutic Stem cells
职业:培训多元化科学家设计用于治疗性干细胞成像和标记的生物纳米材料
- 批准号:
2145427 - 财政年份:2022
- 资助金额:
$ 9.86万 - 项目类别:
Continuing Grant
Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients
针对情绪回路的认知重评训练作为边缘患者的治疗干预
- 批准号:
10436349 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
- 批准号:
10255561 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients
针对情绪回路的认知重评训练作为边缘患者的治疗干预
- 批准号:
10286406 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
- 批准号:
10676262 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
阿片类药物使用障碍虚拟认知情感训练的数字治疗开发
- 批准号:
10624991 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Understanding the role of MeCP2 in the cerebellum and the therapeutic potential of extended training in Rett syndrome
了解 MeCP2 在小脑中的作用以及延长训练对雷特综合征的治疗潜力
- 批准号:
10021407 - 财政年份:2019
- 资助金额:
$ 9.86万 - 项目类别:
A single-blind RCT of a professional development training program for psychotherapists to detect and repair therapeutic alliance tensions
心理治疗师专业发展培训计划的单盲随机对照试验,旨在检测和修复治疗联盟的紧张关系
- 批准号:
417191 - 财政年份:2019
- 资助金额:
$ 9.86万 - 项目类别:
Studentship Programs
Understanding the role of MeCP2 in the cerebellum and the therapeutic potential of extended training in Rett syndrome
了解 MeCP2 在小脑中的作用以及延长训练对雷特综合征的治疗潜力
- 批准号:
10218231 - 财政年份:2019
- 资助金额:
$ 9.86万 - 项目类别: